The influence of soybean extract on the expression level of selected drug transporters, transcription factors and cytochrome P450 genes encoding phase I drug-metabolizing enzymes

Ginekologia Polska

Volumn 85, Issue 5, 2014, Pages 348-353

  Bogacz, Anna ^a,b   Bartkowiak Wieczrek, Joanna ^a,b   Mikołajczak, Przemysław Ł ^a,b   Rakowska Mrozikiewicz, Beata ^c   Grzeskowiak, Edmund ^a   Wolski, Hubert ^a,d   Czerny, Bogusław ^b,e   Mrozikiewicz, Przemysław M ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INSTITUTE OF NATURAL FIBRES AND MEDICINAL PLANTS   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d Division of Gynecology and Obstetrics Podhale Multidisciplinary Hospital   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

CYP enzymes; Expreesion level; Interactions; Soja; Soybean; Transcriptional factors; Transporters; Transportery

Indexed keywords

ALCOHOL DEHYDROGENASE; CYP2D1 PROTEIN, RAT; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; ISOFLAVONE DERIVATIVE; MESSENGER RNA; PLANT EXTRACT;

ANIMAL; ARTICLE; BIOTRANSFORMATION; CHEMISTRY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; INTESTINE MUCOSA; LIVER; METABOLISM; NUCLEOTIDE SEQUENCE; RAT; SOYBEAN; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

ALCOHOL OXIDOREDUCTASES; ANIMALS; BASE SEQUENCE; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION; HUMANS; INTESTINAL MUCOSA; ISOFLAVONES; LIVER; PLANT EXTRACTS; RATS; RATS, WISTAR; RNA, MESSENGER; SOYBEANS;

EID: 84906819543     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: 10.17772/gp/1741     Document Type: Article

References (27)

1. Potter SM, Baum JA, Teng H, [et al.]. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr. 1998, 68, 1375-1379.
2. Dennison E, Yoshimura N, Hashimoto T, Cooper C Bone loss in Great Bretain and Japan: a comparative longitudinal study. Bone. 1998, 23, 379-382.
3. Drews K, Seremak-Mrozikiewicz A, Puk E, [et al.]. Efficacy of standardized isoflavones extract (Soyfen) (52-104 mg/24h) in moderate and medium-severe climacteric syndrome. Ginekol Pol. 2007, 78, 307-311.
4. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999, 70, 439-450.
5. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001, 131, 3095-3108.
6. Persky V, Van Horn L. Epidemiology of soy and cancer: perspectives and directions. J Nutr. 1995, 125, 709-712.
7. Anderson JW, Johnstone BM, Cook-Newell ME, Talalay P. Meta-analysis of the effect of soy protein intake on serum lipids. N Engl J Med. 1995, 333, 276-282.
8. Prestera T, Holtzclaw WD, Zhang Y, [et al.]. Chemical and molecular regulation of enzymes that detoxify carcinogens. Proc Natl Acad Sci USA. 1993, 90, 2965-2969.
9. Guengerich FP. Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals. Ann Rev Nutr. 1984, 4, 207-231.
10. Riddick DS, Lee C, Bhathena A, [et al.]. Transcriptional suppression of cytochrome P450 genes by endogenous and exogenous chemicals. Drug Metab Dispos. 2004, 32, 367-375.
11. Zheng W, Jin F, Dunning LA, [et al.]. Epidemiological study of urinary 6-hydroxycortisol to cortisol ratios and breast cancer risk. Cancer Epidemiol Biomark Prev. 2001, 10, 237-242.
12. Rushmore TH, Kong AN. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr Drug Metab. 2002, 3, 481-90.
13. Ribeiro A, Archer A, Beyec JL, [et al.]. Hepatic nuclear factor-4, a key transcription factor at the crossroads between architecture and function of epithelia. Recent patents on endocrine. Metab Immun Drug Discov. 2007, 1, 166-175.
14. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2008, 9, 105-127.
15. Morris ME, Zhang S. Flavonoid-drug interactions: Effects of flavonoids on ABC transporters. Life Sci. 2006, 78, 2116-2130.
16. Sikic BI. Modulation of multidrug resistance: at the threshold. J Clin Oncol. 1993, 11, 1629-1635.
17. Eichhorn T, Efferth T. P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs. J Ethnopharmacol. 2012, 141, 557-570.
18. Mrozikiewicz PM, Bogacz A, Karasiewicz M, [et al.]. The effect of standardized Echinacea purpurea extract on rat cytochrome P450 expression level. Phytomed. 2010, 17, 830-833.
19. Sugamo T, Nakamura K, Tamura H. Effects of cytochrome P450 inducers on the gene expression of ocular xenobiotic metabolizing enzymes in rats. J Health Sci. 2009, 55, 923-929.
20. Andersson U, Grankvist K, Bergenheim AT, [et al.]. Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation. Med Oncol. 2002, 19, 1-9.
21. Ronis MJ, Rowlands JC, Hakkak R, Badger TM. Inducibility of hepatic enzymes by 3-methylcholantrene and isosafrole differs in male rats fed diets containing casein, soy protein isolate or whey from concentration to adulthood. J Nutr. 2001, 131, 1180-1188.
22. Helsby NA, Williams J, Kerr D, [et al.]. The isoflavones equol and genistein do not induce xenobiotic-metabolizing enzymes in mouse and in human cells. Xenobiotica. 1997, 27, 587-596.
23. Helsby NA, Chipman JK, Gescher A, Kerr D. Inhibition of mouse and human CYP 1A-and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol. 1998, 36, 375-382.
24. Laurenzana EM, Weis CC, Bryant CW, [et al.]. Effect of dietary administration of genistein, nonylphenol or ethinyl estradiol on hepatic testosterone metabolism cytochrome P-450 enzymes, and estrogen receptor alpha expression. Food Chem Toxicol. 2002, 40, 53-63.
25. Anderson GD, Rosito G, Mohustsy MA, Elmer GW. Drug interaction potential of soy extract and Panax ginseng. J Clin Pharmacol. 2003, 43, 643-648.
26. Singhal R, Badger TM, Ronis MJ. Rats fed soy protein isolate (SPI) have impaired hepatic CYP1A1 induction by polycyclic aromatic hydrocarbons as a result of interference with aryl hydrocarbon receptor signaling. Toxicol Appl Pharmacol. 2008, 227, 275-283.
27. Li Y, Ross-Viola JS, Shay NF, [et al.]. Human CYP3A4 and murine CYP3A11 are regulated by equol and genistein via the pregnane X receptor in a species-specific manner. J Nutr. 2009, 139, 898-904.